Dimensional Fund Advisors
EWTX icon

Dimensional Fund Advisors’s Edgewise Therapeutics EWTX Stock Holding History

Dimensional Fund Advisors’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.3M Sell
1,139,726
-79,991
-7% -$2.76M 0.01% 1635
2026
Q1 		$38.4M Buy
1,219,717
+6,060
+0.5% +$175K 0.01% 1647
2025
Q4 		$30.1M Buy
1,213,657
+30,521
+3% +$613K 0.01% 1773
2025
Q3 		$19.2M Buy
1,183,136
+134,200
+13% +$1.9M ﹤0.01% 2006
2025
Q2 		$13.8M Buy
1,048,936
+381,437
+57% +$5.5M ﹤0.01% 2141
2025
Q1 		$14.7M Sell
667,499
-62,424
-9% -$1.64M ﹤0.01% 2085
2024
Q4 		$19.5M Buy
729,923
+3,052
+0.4% +$97.2K ﹤0.01% 2003
2024
Q3 		$19.4M Buy
726,871
+259,364
+55% +$5.16M ﹤0.01% 2018
2024
Q2 		$8.42M Buy
467,507
+168,219
+56% +$2.93M ﹤0.01% 2331
2024
Q1 		$5.46M Buy
299,288
+37,050
+14% +$589K ﹤0.01% 2526
2023
Q4 		$2.87M Buy
262,238
+87,317
+50% +$613K ﹤0.01% 2706
2023
Q3 		$1M Buy
174,921
+101,863
+139% +$692K ﹤0.01% 2927
2023
Q2 		$566K Buy
73,058
+45,775
+168% +$386K ﹤0.01% 3038
2023
Q1 		$182K Buy
+27,283
New +$253K ﹤0.01% 3221
2022
Q3 		$258K Buy
+26,180
New +$265K ﹤0.01% 3194

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors's EWTX Position: Q2 2026 in Review

Dimensional Fund Advisors reduced its Edgewise Therapeutics (EWTX) stake by 6.6% in Q2 2026, selling an estimated $2.76M and leaving 1,139,726 shares worth $46.3M. The position accounts for 0.01% of the portfolio, ranked #1635.

Dimensional Fund Advisors first reported a position in EWTX in Q3 2022 and has held it in 15 quarters since. 226 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Dimensional Fund Advisors held 1,139,726 shares of Edgewise Therapeutics worth $46.3M as of Q2 2026.
  • Dimensional Fund Advisors sold 79,991 Edgewise Therapeutics shares in Q2 2026, an estimated $2.76M.
  • Edgewise Therapeutics made up 0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #1635 holding.
  • Dimensional Fund Advisors first reported a position in Edgewise Therapeutics in Q3 2022 and has held it in 15 quarters since.
  • 226 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.